Last $10.96 USD
Change Today +0.31 / 2.91%
Volume 274.8K
As of 4:30 PM 07/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

K. Frank Austen M.D.

Member of Scientific Advisory Board, Momenta Pharmaceuticals Inc.
AgeTotal Calculated CompensationThis person is connected to 64 board members in 6 different organizations across 7 different industries.

See Board Relationships


Prof. K. Frank Austen, M.D. serves as Director of Inflammation & Allergic Diseases Research Section and Professor of Respiratory & Inflammatory Disease of Brigham and Women's Hospital, Boston, MA. Dr. Austen served as Professor of Medicine and Respiratory & Inflammatory Diseases of Harvard Medical School. He served as Captain in the U.S. Army Medical Corps at Walter Reed Army Institute of Research. He served at AstraZeneca Professorship of Respiratory and Inflammatory ...

Read Full Background

Corporate Headquarters*

675 West Kendall Street
Cambridge, Massachusetts 02142

United States

Phone: 617-491-9700
Fax: 617-621-0431

Board Members Memberships*

Former Director


Unknown/Other Education
Amherst College
Harvard Medical School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MNTA:US $10.96 USD +0.31


Ted William Karkus Chairman and Chief Executive Officer
ProPhase Labs, Inc.
Douglas A. Michels Chief Executive Officer, President and Director
OraSure Technologies, Inc.
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
Scott L. Tarriff Chief Executive Officer, President and Director
Eagle Pharmaceuticals Inc.
Venkaiah Chowdary Nannapaneni M. Pharm M SChairman, Managing Director, Chairman of Allotment Committee, Member of Audit Committee, Member of Compensation Committee and Member of Investor Grievance Committee
Natco Pharma Limited
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MOMENTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at